Glox Therapeutics, situated in Glasgow and dedicated to developing precise antibiotic treatments centered on naturally derived bacteriocins, has successfully raised £4.3 million (around €4.93 million) in its initial seed funding round.
Glox Therapeutics, situated in Glasgow and dedicated to developing precise antibiotic treatments centered on naturally derived bacteriocins, has successfully raised £4.3 million (around €4.93 million) in its initial seed funding round.
Naïf, a B-Corp in South Holland Creating Skin-Friendly Care Products, Secures €23M Investment from European Impact Investor Future Business Partnership (FBP)"
Fnality, headquartered in London and specializing in the development of wholesale payment systems based on Distributed Ledger Technology (DLT), revealed its successful completion of a Series B funding round, amassing £77.7 million (approximately €89 million).
IQONIC.AI, headquartered in Berlin and formerly known as SQIN, an AI-focused company, revealed that it has successfully raised a seven-figure seed funding round with support from Brandenburg Kapital, YZR Capital, and Arve Capital.
Amsterdam-headquartered VectorY Therapeutics, a prominent biotechnology company, unveiled its successful fundraising effort on Monday, securing €129 million in a Series A funding round, jointly led by EQT Life Sciences and the Forbion Growth Opportunities Fund.
Aikido Security, headquartered in Ghent and specializing in software security applications designed for SaaS companies, has revealed the successful acquisition of €5 million in funding through a Seed round.
Otovo, headquartered in Oslo and operating as a marketplace for solar and battery storage solutions, has revealed the successful completion of a new funding round, securing €40 million (equivalent to approximately NOK 450 million).
Journal Lab, a Rotterdam-based digital platform that allows travelers to document their journeys in photo-rich diaries at no cost, has revealed the successful acquisition of €1.2 million in funding.
